RGNX
REGENXBIO Inc.
Latest close $10.50 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 3 parsed filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| JPMorgan Chase / Asset Management CIK0000019617 | May 29, 2026 observed Jun 4, 2026 filed · 6d Schedule 13G amendment | Earliest Schedule 13G amendment found | 2.3M | 12.00% | $7.01 | $6.88 | $10.50 |
| State Street CIK0000093751 | Mar 31, 2026 observed May 12, 2026 filed · 42d Initial Schedule 13G | Initial Schedule 13G | 2.7M | 12.00% | $8.38 | $10.24 | $10.50 |
| BlackRock Legacy CIK0001364742 | Dec 31, 2023 observed Jan 19, 2024 filed · 19d Schedule 13G amendment | Earliest Schedule 13G amendment found | 8.2M | 18.70% | $10.50 |